Mushtaq, A., Ashruf, O., Cripe, L., Singh, A., Molina, J., Carraway, H., Mukherjee, S., Gerds, A., Jain, A. (2025). Comparative risk of major adverse cardiovascular events in polycythemia vera patients treated with ruxolitinib, hydroxyurea, or interferon: A real-world, propensity-matched cohort study. Blood. https://doi.org/10.1182/blood-2025-3826